LEVORA 0.15/30-28 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levora 0.15/30-28, and when can generic versions of Levora 0.15/30-28 launch?
Levora 0.15/30-28 is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.
The generic ingredient in LEVORA 0.15/30-28 is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for LEVORA 0.15/30-28
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LEVORA 0.15/30-28 at DailyMed |
Recent Clinical Trials for LEVORA 0.15/30-28
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AbbVie | Phase 1 |
Intarcia Therapeutics | Phase 1 |
University of California, Davis | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for LEVORA 0.15/30-28
US Patents and Regulatory Information for LEVORA 0.15/30-28
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys Labs Sa | LEVORA 0.15/30-28 | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 073594-001 | Dec 13, 1993 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |